BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hossain MJ, Tanasescu R, Gran B. Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2. J Neuroimmunol. 2017;304:11-20. [PMID: 28007303 DOI: 10.1016/j.jneuroim.2016.12.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Dawod B, Haidl ID, Azad MB, Marshall JS. Toll-like receptor 2 impacts the development of oral tolerance in mouse pups via a milk-dependent mechanism. Journal of Allergy and Clinical Immunology 2020;146:631-641.e8. [DOI: 10.1016/j.jaci.2020.01.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Du Z, Feng X, Li N, Qu J, Feng L, Chen L, Chen W. G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia. Phytomedicine 2018;43:11-20. [DOI: 10.1016/j.phymed.2018.03.039] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
3 Ashayeri Ahmadabad R, Mirzaasgari Z, Gorji A, Khaleghi Ghadiri M. Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders. Int J Mol Sci 2021;22:6153. [PMID: 34200356 DOI: 10.3390/ijms22116153] [Reference Citation Analysis]
4 Xun Y, Yang H, Kaminska B, You H. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma. J Hematol Oncol 2021;14:176. [PMID: 34715891 DOI: 10.1186/s13045-021-01191-2] [Reference Citation Analysis]
5 Noorbakhsh SM, Razavi A, Moghadam NB, Saadat P, Hoseini M, Aghazadeh Z, Mobini M, Oraei M, Mirshafiey A. Effects of guluronic acid (G2013) on gene expression of TLR2, TLR4, MyD88, TNF-α and CD52 in multiple sclerosis under in vitro conditions. Immunopharmacology and Immunotoxicology 2019;41:586-90. [DOI: 10.1080/08923973.2019.1672179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Liu A, Manuel AM, Dai Y, Zhao Z. Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment. BMC Genomics 2022;23:362. [PMID: 35545758 DOI: 10.1186/s12864-022-08580-y] [Reference Citation Analysis]
7 Deeba E, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. BMC Res Notes 2020;13:460. [PMID: 32993761 DOI: 10.1186/s13104-020-05300-1] [Reference Citation Analysis]
8 Esser S, Göpfrich L, Bihler K, Kress E, Nyamoya S, Tauber SC, Clarner T, Stope MB, Pufe T, Kipp M, Brandenburg LO. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination. Mol Neurobiol 2018;55:6237-49. [PMID: 29288338 DOI: 10.1007/s12035-017-0838-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ashayeri Ahmadabad R, Khaleghi Ghadiri M, Gorji A. The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarization. J Neuroinflammation 2020;17:108. [PMID: 32264928 DOI: 10.1186/s12974-020-01785-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Hossain MJ, Morandi E, Tanasescu R, Frakich N, Caldano M, Onion D, Faraj TA, Erridge C, Gran B. The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker. Front Immunol 2018;9:457. [PMID: 29593720 DOI: 10.3389/fimmu.2018.00457] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
11 Yu Y, Shen Q, Lai Y, Park SY, Ou X, Lin D, Jin M, Zhang W. Anti-inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol 2018;9:386. [PMID: 29731715 DOI: 10.3389/fphar.2018.00386] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
12 Shahba S, Mehrzad J, Malvandi AM. Neuroimmune disruptions from naturally occurring levels of mycotoxins. Environ Sci Pollut Res Int 2021. [PMID: 33932215 DOI: 10.1007/s11356-021-14146-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Dixon GA, Pérez CA. Multiple Sclerosis and the Choroid Plexus: Emerging Concepts of Disease Immunopathophysiology. Pediatr Neurol 2020;103:65-75. [PMID: 31780202 DOI: 10.1016/j.pediatrneurol.2019.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Hermann JK, Capadona JR. Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes. Crit Rev Biomed Eng 2018;46:341-67. [PMID: 30806249 DOI: 10.1615/CritRevBiomedEng.2018027166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Sahasrabudhe NM, Beukema M, Tian L, Troost B, Scholte J, Bruininx E, Bruggeman G, van den Berg M, Scheurink A, Schols HA, Faas MM, de Vos P. Dietary Fiber Pectin Directly Blocks Toll-Like Receptor 2-1 and Prevents Doxorubicin-Induced Ileitis. Front Immunol 2018;9:383. [PMID: 29545800 DOI: 10.3389/fimmu.2018.00383] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
16 Murugan S, Jakka P, Namani S, Mujumdar V, Radhakrishnan G. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. J Biol Chem 2019;294:4596-607. [PMID: 30647133 DOI: 10.1074/jbc.RA118.005543] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
17 Abadi ATB. Strategies used by helicobacter pylori to establish persistent infection. World J Gastroenterol 2017; 23(16): 2870-2882 [PMID: 28522905 DOI: 10.3748/wjg.v23.i16.2870] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
18 Zhang WD, Li N, Du ZR, Zhang M, Chen S, Chen WF. IGF-1 receptor is involved in the regulatory effects of icariin and icaritin in astrocytes under basal conditions and after an inflammatory challenge. Eur J Pharmacol 2021;906:174269. [PMID: 34147477 DOI: 10.1016/j.ejphar.2021.174269] [Reference Citation Analysis]
19 Büki B, Jünger H, Zhang Y, Lundberg YW. The Price of Immune Responses and the Role of Vitamin D in the Inner Ear. Otol Neurotol 2019;40:701-9. [PMID: 31194714 DOI: 10.1097/MAO.0000000000002258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Ferret-Sena V, Capela C, Sena A. Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis. Int J Mol Sci 2018;19:E1639. [PMID: 29865151 DOI: 10.3390/ijms19061639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
21 Labib DA, Ashmawy I, Elmazny A, Helmy H, Ismail RS. Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients. Int J Neurosci 2020;:1-5. [PMID: 32842834 DOI: 10.1080/00207454.2020.1812601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Morandi E, Tanasescu R, Tarlinton RE, Constantin-Teodosiu D, Gran B. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus? Front Immunol 2018;9:3092. [PMID: 30740110 DOI: 10.3389/fimmu.2018.03092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Deeba E, Koptides D, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients. Mult Scler Relat Disord 2019;33:100-6. [PMID: 31177052 DOI: 10.1016/j.msard.2019.05.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Liguori M, Nuzziello N, Licciulli F, Consiglio A, Simone M, Viterbo RG, Creanza TM, Ancona N, Tortorella C, Margari L, Grillo G, Giordano P, Liuni S, Trojano M. Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. Hum Mol Genet 2018;27:66-79. [PMID: 29087462 DOI: 10.1093/hmg/ddx385] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
25 Wu ZS, Lo JJ, Wu SH, Wang CZ, Chen RF, Lee SS, Chai CY, Huang SH. Early Hyperbaric Oxygen Treatment Attenuates Burn-Induced Neuroinflammation by Inhibiting the Galectin-3-Dependent Toll-Like Receptor-4 Pathway in a Rat Model. Int J Mol Sci. 2018;19. [PMID: 30060489 DOI: 10.3390/ijms19082195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]